Trials / Completed
CompletedNCT03756753
The RAPID Trial: Assessing Point-of-care Influenza and Other Respiratory Virus Diagnostics
The RAPID Trial: Randomized Controlled Trial Assessing Point-of-care Influenza and Other Respiratory Virus Diagnostics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 913 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 1 Month – 18 Years
- Healthy volunteers
- Not accepted
Summary
The RAPID trial is a randomized controlled trial that looks at the clinical impact of a rapid respiratory test in a pediatric emergency department. Participants will be randomized to the intervention group - results available to medical providers, or the control group- results not available to medical providers.
Detailed description
The RAPID trial is a randomized controlled trial of rapid respiratory viral testing in children presenting to an Emergency Department setting with acute respiratory symptoms. The patient cohort will be children 1 month to 18 years of age presenting to the Children's Hospital Colorado (CHCO) Emergency Department with influenza like illness who are triaged as level 3, 4, or 5 by the Emergency Severity Index, representing the typical patient population who are evaluated in an urgent care setting. All eligible participants will undergo a nasopharyngeal swab and point of care testing, and participants will be allocated 1:1 by computer-generated randomization to either the intervention group - test result available to providers, or the control group- test result not available (routine clinical care). The investigators will compare the clinical outcomes between the two groups.
Conditions
- Respiratory Pathogens
- Upper Respiratory Tract Illness
- Lower Respiratory Tract Illness
- Acute Respiratory Infection
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Results available to provider | Results of point of care testing are given to provider |
Timeline
- Start date
- 2019-01-03
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2018-11-28
- Last updated
- 2021-11-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03756753. Inclusion in this directory is not an endorsement.